AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 293: H3768-H3771, 2007. First published October 5, 2007; doi:10.1152/ajpheart.00486.2007
0363-6135/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/6/H3768    most recent
00486.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hambleton, M.
Right arrow Articles by Molkentin, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hambleton, M.
Right arrow Articles by Molkentin, J. D.

REPORT

Inducible and myocyte-specific inhibition of PKC{alpha} enhances cardiac contractility and protects against infarction-induced heart failure

Michael Hambleton,1 Allen York,1 Michelle A. Sargent,1 Robert A. Kaiser,1 John N. Lorenz,2 Jeffrey Robbins,1 and Jeffery D. Molkentin1

1Department of Pediatrics, Cincinnati Children's Hospital Medical Center, and 2Department of Molecular and Cellular Physiology, University of Cincinnati, Cincinnati, Ohio

Submitted 23 April 2007 ; accepted in final form 1 October 2007

Mice null for the gene encoding protein kinase C{alpha} (Prkca), or mice treated with pharmacologic inhibitors of the PKC{alpha}/β/{gamma} isoforms, show an augmentation in cardiac contractility that appears to be cardioprotective. However, it remains uncertain if PKC{alpha} itself functions in a myocyte autonomous manner to affect cardioprotection in vivo. Here we generated cardiac myocyte-specific transgenic mice using a tetracycline-inducible system to permit controlled expression of dominant negative PKC{alpha} in the heart. Consistent with the proposed function of PKC{alpha}, induction of dominant negative PKC{alpha} expression in the adult heart enhanced baseline cardiac contractility. This increase in cardiac contractility was associated with a partial protection from long-term decompensation and secondary dilated cardiomyopathy after myocardial infarction injury. Similarly, Prkca null mice were also partially protected from infarction-induced heart failure, although the area of infarction injury was identical to controls. Thus, myocyte autonomous inhibition of PKC{alpha} protects the adult heart from decompensation and dilated cardiomyopathy after infarction injury in association with a primary enhancement in contractility.

protein kinase C; signaling; myocardial infarction



Address for reprint requests and other correspondence: J. D. Molkentin, Division of Molecular Cardiovascular Biology, Dept. of Pediatrics, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave., Cincinnati, Ohio 45229-3039 USA (e-mail: jeff.molkentin{at}cchmc.org)




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Koyanagi, L. Y. Wong, K. Inagaki, O. V. Petrauskene, and D. Mochly-Rosen
Alteration of gene expression during progression of hypertension-induced cardiac dysfunction in rats
Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H220 - H226.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.